secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2026-08-28T12:01:39+00:00
Accession:  0001539497-26-002373
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla faces Nasdaq delisting; trading to suspend Aug 31
---------------------------------------------------------

- Nasdaq Listing Council affirmed delisting on Aug 26, 2026; suspension at open Aug 31, 2026.
- Delisting due to bid price below $1.00 and failure to meet $2.5M stockholders' equity requirement.
- Company expects OTC Markets quotation under ticker BCAB; liquidity and trading price may be materially affected.
- Strategic review process initiated March 2026 to explore shareholder value alternatives remains ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000153949726002373/0001539497-26-002373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000153949726002373/n5620_x8-8k.htm
  HTML page:      https://secwatch.observer/filing/0001539497-26-002373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer